Peter Stein

Biography

Peter Stein is the Chairman and Chief Executive Officer and principal shareholder of the Norgine Group. Norgine B.V., the primary subsidiary of the group, is a European specialist pharmaceutical company with operations throughout Europe, Australia and New Zealand. Peter also serves as the Chief Executive of Norgine Ventures, which provides financing solutions to innovative healthcare companies. Prior to joining Norgine in 1987, Peter was a co-founder and Vice President of Invitron Corporation, a contract biomanufacturer formed as a spin-off from the Monsanto Company. He started his pharmaceutical career with Centocor. Peter holds BA and MA degrees in Chemistry from Harvard University and an MBA from Stanford University. In addition to his role at Norgine, Peter is a non-executive Director of Agendia N.V., a molecular diagnostics company based in Amsterdam. Peter Stein is the Chairman and Chief Executive Officer and principal shareholder of the Norgine Group. Norgine B.V., the primary subsidiary of the group, is a European specialist pharmaceutical company with operations throughout Europe, Australia and New Zealand. Peter also serves as the Chief Executive of Norgine Ventures, which provides financing solutions to innovative healthcare companies. Prior to joining Norgine in 1987, Peter was a co-founder and Vice President of Invitron Corporation, a contract biomanufacturer formed as a spin-off from the Monsanto Company. He started his pharmaceutical career with Centocor. Peter holds BA and MA degrees in Chemistry from Harvard University and an MBA from Stanford University. In addition to his role at Norgine, Peter is a non-executive Director of Agendia N.V., a molecular diagnostics company based in Amsterdam.

Research Interest

research and development, engineering and management